Literature DB >> 29508103

Utility of Using the Montreal Cognitive Assessment (MoCA) as a Screening Tool for HIV-Associated Neurocognitive Disorders (HAND) In Multi-Ethnic Malaysia.

Trena Mukherjee1, Rishanantini Sakthivel2, Ho Yen Fong2, Megan McStea2, Meng Li Chong2, Sharifah Faridah Omar2,3, Ai Vyrn Chin3, Shahrul Kamaruzzaman3, Adeeba Kamarulzaman2,3, Reena Rajasuriar4,5,6, Lucette A Cysique7.   

Abstract

This study determines the optimal cut-off scores for the Montreal Cognitive Assessment (MoCA) to detect HIV-associated neurocognitive disorders (HAND) in a multi-ethnic Malaysian HIV-positive cohort by developing demographically corrected normative standards among 283 HIV-negative community-based controls with overlapping demographic characteristics. The norms (corrected for age, sex, education, ethnicity) were applied to 342 HIV-positive virally suppressed individuals on cART. Impairment rates were classified using the Global Deficit Score (GDS ≥ .5) method. The MoCA was also scored according to the recommended cut-off of ≤ 26, and functional decline was applied to both impairment definitions to classify HAND per the Frascati criteria. The ≤ 26 cut-off considerably overestimated cognitive impairment in both samples (59.4% HIV-negative; 69.3% HIV-positive). In contrast, corrected scores yielded impairment rates consistent with what has been reported internationally in virally suppressed cohorts (23.4% with 83.3% mild impairment, 16.7% moderate impairment). A supplemental file allowing the computation of corrected MoCA scores and impairment status is included.

Entities:  

Keywords:  HIV; Hand; Malaysia; MoCA; Normative values

Mesh:

Year:  2018        PMID: 29508103      PMCID: PMC6123290          DOI: 10.1007/s10461-018-2073-x

Source DB:  PubMed          Journal:  AIDS Behav        ISSN: 1090-7165


  33 in total

1.  Predictive validity of global deficit scores in detecting neuropsychological impairment in HIV infection.

Authors:  Catherine L Carey; Steven Paul Woods; Raul Gonzalez; Emily Conover; Thomas D Marcotte; Igor Grant; Robert K Heaton
Journal:  J Clin Exp Neuropsychol       Date:  2004-05       Impact factor: 2.475

2.  The Montreal Cognitive Assessment, MoCA: a brief screening tool for mild cognitive impairment.

Authors:  Ziad S Nasreddine; Natalie A Phillips; Valérie Bédirian; Simon Charbonneau; Victor Whitehead; Isabelle Collin; Jeffrey L Cummings; Howard Chertkow
Journal:  J Am Geriatr Soc       Date:  2005-04       Impact factor: 5.562

3.  HIV-associated neurocognitive disorders persist in the era of potent antiretroviral therapy: CHARTER Study.

Authors:  R K Heaton; D B Clifford; D R Franklin; S P Woods; C Ake; F Vaida; R J Ellis; S L Letendre; T D Marcotte; J H Atkinson; M Rivera-Mindt; O R Vigil; M J Taylor; A C Collier; C M Marra; B B Gelman; J C McArthur; S Morgello; D M Simpson; J A McCutchan; I Abramson; A Gamst; C Fennema-Notestine; T L Jernigan; J Wong; I Grant
Journal:  Neurology       Date:  2010-12-07       Impact factor: 9.910

4.  HIV-associated neurocognitive disorder in HIV-infected Koreans: the Korean NeuroAIDS Project.

Authors:  N S Ku; Y Lee; J Y Ahn; J E Song; M H Kim; S B Kim; S J Jeong; K-W Hong; E Kim; S H Han; J Y Song; H J Cheong; Y G Song; W J Kim; J M Kim; D M Smith; J Y Choi
Journal:  HIV Med       Date:  2014-02-24       Impact factor: 3.180

5.  Validity of the MoCA and MMSE in the detection of MCI and dementia in Parkinson disease.

Authors:  S Hoops; S Nazem; A D Siderowf; J E Duda; S X Xie; M B Stern; D Weintraub
Journal:  Neurology       Date:  2009-11-24       Impact factor: 9.910

6.  Predictive validity of demographically adjusted normative standards for the HIV Dementia Scale.

Authors:  Erin E Morgan; Steven Paul Woods; J Cobb Scott; Meredith Childers; Jennifer Marquie Beck; Ronald J Ellis; Igor Grant; Robert K Heaton
Journal:  J Clin Exp Neuropsychol       Date:  2007-04-20       Impact factor: 2.475

7.  Defining neurocognitive impairment in HIV: deficit scores versus clinical ratings.

Authors:  K Blackstone; D J Moore; D R Franklin; D B Clifford; A C Collier; C M Marra; B B Gelman; J C McArthur; S Morgello; D M Simpson; R J Ellis; J H Atkinson; I Grant; R K Heaton
Journal:  Clin Neuropsychol       Date:  2012-06-18       Impact factor: 3.535

8.  HIV-associated neurocognitive disorders (HAND) in a South Asian population - contextual application of the 2007 criteria.

Authors:  Lai Gwen Chan; Nagaendran Kandiah; Arlene Chua
Journal:  BMJ Open       Date:  2012-02-13       Impact factor: 2.692

Review 9.  Validity of cognitive screens for HIV-associated neurocognitive disorder: a systematic review and an informed screen selection guide.

Authors:  Jody Kamminga; Lucette A Cysique; Grace Lu; Jennifer Batchelor; Bruce J Brew
Journal:  Curr HIV/AIDS Rep       Date:  2013-12       Impact factor: 5.071

Review 10.  The Chronicity of HIV Infection Should Drive the Research Strategy of NeuroHIV Treatment Studies: A Critical Review.

Authors:  Thomas M Gates; Lucette A Cysique
Journal:  CNS Drugs       Date:  2016-01       Impact factor: 5.749

View more
  6 in total

1.  Functional deficits and other psychiatric associations with abnormal scores on the Montreal Cognitive Assessment (MoCA) in older HIV-infected patients.

Authors:  James A Bourgeois; Malcolm John; Roland Zepf; Meredith Greene; Steven Frankel; Nancy A Hessol
Journal:  Int Psychogeriatr       Date:  2020-01       Impact factor: 3.878

Review 2.  Screening for HIV-Associated Neurocognitive Disorders: Sensitivity and Specificity.

Authors:  Reuben N Robbins; Travis M Scott; Hetta Gouse; Thomas D Marcotte; Sean B Rourke
Journal:  Curr Top Behav Neurosci       Date:  2021

3.  Screening Accuracy of Mini Addenbrooke's Cognitive Examination Test for HIV-Associated Neurocognitive Disorders in People Ageing with HIV.

Authors:  Mattia Trunfio; Davide De Francesco; Daniela Vai; Caterina Medina; Maurizio Milesi; Simone Domini; Chiara Alcantarini; Daniele Imperiale; Stefano Bonora; Giovanni Di Perri; Andrea Calcagno
Journal:  AIDS Behav       Date:  2022-01-04

4.  Application of Diffusion Tensor Imaging (DTI) in the Diagnosis of HIV-Associated Neurocognitive Disorder (HAND): A Meta-Analysis and a System Review.

Authors:  Juming Ma; Xue Yang; Fan Xu; Hongjun Li
Journal:  Front Neurol       Date:  2022-07-07       Impact factor: 4.086

5.  Neurocognitive performance and quality of life of older adults with HIV on antiretroviral treatment in Northern Thailand.

Authors:  Linda Aurpibul; Patumrat Sripan; Arunrat Tangmunkongvorakul; Wilawan Chaikan; Saowalak Sarachai; Kriengkrai Srithanaviboonchai
Journal:  J Int AIDS Soc       Date:  2022-09       Impact factor: 6.707

6.  Prevalence and Correlates of Neurocognitive Disorders among HIV Patients on Antiretroviral Therapy at a Kenyan Hospital.

Authors:  A G Mugendi; M N Kubo; D G Nyamu; L M Mwaniki; S K Wahome; J E Haberer
Journal:  Neurol Res Int       Date:  2019-10-30
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.